MARKET

BTAIQ

BTAIQ

Bioxcel Therapeutics Inc
OTCPK
0.043
-0.031
-42.08%
Closed 15:59 09/08 EDT
OPEN
0.020
PREV CLOSE
0.074
HIGH
0.043
LOW
0.020
VOLUME
3.28M
TURNOVER
117.87K
52 WEEK HIGH
4.290
52 WEEK LOW
0.020
MARKET CAP
1.34M
P/E (TTM)
-0.0113
1D
5D
1M
3M
1Y
5Y
1D
*News On BioXcel Therapeutics Inc. (BTAI) Now Under BTAIQ
Dow Jones · 8h ago
Weekly Report: what happened at BTAI last week (0831-0904)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 4d ago
Weekly Buzz: IONS, MIST, BIIB, AZN Win Nods; TCRX, NVS Cut Jobs; OVID, VIR Data; REGN, PASG Deals
NASDAQ · 4d ago
Dow Falls Over 100 Points; US Economy Adds 162,000 Jobs In August
Benzinga · 4d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 4d ago
Why Samsara Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 4d ago
More
About BTAIQ
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics LLC, is focused on the development of medicines in immuno-oncology. Its advanced neuroscience candidate, BXCL501, is an investigational, orally dissolving film formulation of dexmedetomidine in development for the treatment of agitation associated with psychiatric and neurological disorders. It is continuing to develop BXCL501 for the potential acute treatment of agitation associated with bipolar disorder or schizophrenia in the at-home setting and for the potential acute treatment of agitation (non-daily) associated with dementia due to probable Alzheimer’s disease in the at-home setting and in care facilities. Its advanced immuno-oncology candidate, BXCL701, is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors.

Webull offers BioXcel Therapeutics Inc stock information, including OTCPK: BTAIQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BTAIQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BTAIQ stock methods without spending real money on the virtual paper trading platform.